Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.

Moss RB, Mayer-Hamblett N, Wagener J, et al. "Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease." Pediatr. Pulmonol.. 2005;39(3):209-18.